Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Pillars Article: production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med. 1986. 163: 1037-1050.

Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, Sporn MB, Fauci AS.

J Immunol. 2014 Apr 1;192(7):2939-52. No abstract available.

2.

Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production. J. Exp. Med. 1989. 170: 1415-1420.

Sonoda E, Matsumoto R, Hitoshi Y, Ishii T, Sugimoto M, Araki S, Tominaga A, Yamaguchi N, Takatsu K.

J Immunol. 2009 Jan 1;182(1):14-9. No abstract available.

3.
4.

Pillars article: Identification of a T cell-derived B cell growth factor distinct from interleukin 2. J. Exp. Med. 1982. 155: 914-923.

Howard M, Farrar J, Hilfiker M, Johnson B, Takatsu K, Hamaoka T, Paul WE.

J Immunol. 2013 Feb 1;190(3):864-73. No abstract available.

6.

Suppressing autoimmunity by TGF-β: not just through T(reg) cells.

He MX, He YW.

Cell Mol Immunol. 2012 Sep;9(5):371-2. doi: 10.1038/cmi.2012.24. No abstract available.

7.

Pillars article: T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells. J. Exp. Med. 1982. 155: 734-748.

Isakson PC, Puré E, Vitetta ES, Krammer PH.

J Immunol. 2013 Feb 1;190(3):849-63. No abstract available.

8.

Human retinal pigment epithelium-induced CD4+CD25+ regulatory T cells suppress activation of intraocular effector T cells.

Horie S, Sugita S, Futagami Y, Yamada Y, Mochizuki M.

Clin Immunol. 2010 Jul;136(1):83-95. doi: 10.1016/j.clim.2010.03.001.

PMID:
20350837
9.

TGF-β puts the brakes on homeostatic proliferation.

Surh CD, Sprent J.

Nat Immunol. 2012 Jun 19;13(7):628-30. doi: 10.1038/ni.2345. No abstract available.

PMID:
22713819
10.

A two-hit model of autoimmunity: lymphopenia and unresponsiveness to TGF-β signaling.

L'Huillier A, Ren G, Shi Y, Zhang J.

Cell Mol Immunol. 2012 Sep;9(5):369-70. doi: 10.1038/cmi.2012.25. No abstract available.

11.

Close bonding: the first report of TGF-β and T cells.

Li MO.

J Immunol. 2014 Apr 1;192(7):2937-8. doi: 10.4049/jimmunol.1400405. No abstract available.

12.

Transforming growth factor-beta in T-cell biology.

Gorelik L, Flavell RA.

Nat Rev Immunol. 2002 Jan;2(1):46-53. Review.

PMID:
11905837
13.

[The liver and the immune system].

Jakab L.

Orv Hetil. 2015 Jul 26;156(30):1203-13. doi: 10.1556/650.2015.30190. Review. Hungarian.

PMID:
26186144
14.

Circulatory levels of T-cell cytokines (interleukin [IL]-2, IL-4, IL-17, and transforming growth factor-β) in patients with vitiligo.

Khan R, Gupta S, Sharma A.

J Am Acad Dermatol. 2012 Mar;66(3):510-1. doi: 10.1016/j.jaad.2011.07.018. No abstract available.

PMID:
22342018
16.

TGF-beta: 20 years and counting.

Sporn MB.

Microbes Infect. 1999 Dec;1(15):1251-3.

PMID:
10611752
17.
19.
20.

Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes.

Valenti R, Huber V, Filipazzi P, Pilla L, Sovena G, Villa A, Corbelli A, Fais S, Parmiani G, Rivoltini L.

Cancer Res. 2006 Sep 15;66(18):9290-8.

Items per page

Supplemental Content

Support Center